India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates ...

India’s Central Drugs Standard Control Organization warns pharma companies against promoting GLP-1 receptor agonists directly to consumers.

By Rishika Sadam March 11 (Reuters) - India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns ...

The US has already reported more than 1,100 measles cases in the first two months of 2026 — six times more than has been ...

The study did not meet its primary objective of a statistically significant improvement in progression-free survival in the intent-to-treat population versus letrozole plus palbociclib, but a ...

NKGen Biotech, Inc. (OTC: NKGN) ('NKGen” or the 'Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

Russia's invasion of Ukraine four years ago launched Europe's biggest conflict since World War II ...

Spokesman for the UN secretary-general said this will be the “first time a First Lady, or first gentleman, for that matter, has ever presided over" a UNSC meet.

European drug regulators are endorsing a new and simpler treatment for sleeping sickness, in what could be a giant boost to efforts to eliminate the disease. A European Medicines Agency ...

On Jan. 20, 2025, President Donald Trump signed a 90-day freeze on all foreign assistance. Within weeks, USAID, which had operated for more than six decades, was shut down.

Breast cancer is the most diagnosed cancer among women globally, and the number of cases worldwide is estimated to reach over ...

Last year, Peking Union began hosting a rare diseases forum, with 10 delegations from China (including Hong Kong, Macao and Taiwan), and other regions and countries participating. Two international ...